Diabetes and Postprandial Glycaemic Control
The sponsor’s clinical research includes Type 1 diabetes, with attention to post-meal blood glucose regulation, rapid-acting mealtime insulin, and the metabolic consequences of hyperglycaemia.
- Postprandial glucose profiles
- Rapid-acting insulin therapy
- Oxidative stress
Interest in this area centres on matching insulin action to gastric emptying and improving metabolic stability after meals.
Heart Failure and Cardiometabolic Disease
Another area of activity is heart failure with preserved ejection fraction (HFpEF), including cases with or without metabolic dysfunction-associated steatotic liver disease (MASLD), reflecting a focus on intertwined cardiac and metabolic conditions.
- HFpEF
- MASLD
- Cardiometabolic disorders
The research landscape addresses how metabolic abnormalities intersect with heart failure symptoms and functional limitation.
Metabolic Regulation and Glucagon Biology
Work funded by the sponsor also examines glucagon in relation to metabolism, with interest in its effects on energy balance and related physiological responses in HFpEF.
- Glucagon
- Metabolic effects
- Energy utilisation
This domain links endocrine regulation to broader cardiometabolic function.
Physical Performance and Exercise Capacity
The sponsor shows interest in physical performance outcomes, including exercise tolerance and VO2max, particularly in patients with HFpEF and associated metabolic disease.
- VO2max
- Exercise capacity
- Functional status
These studies connect cardiovascular symptoms with measurable limitations in daily physical activity.
